Pharmeasy Planning For IPO Again After 2 Years. Is It Final?
After 2 years of pulling back its IPO, Pharmeasy is in talks to relaunch its IPO. According to the Economic Times, this is part of Pharmeasy’s renewed strategy aims to sustain financially by merging with its listed subsidiary, Thyrocare. Will PharmEasy go for IPO? According to a source quoted by ET, Pharmeasy will present its […]
PharmEasy Sees A 92% Cut In Valuation At $458 Million
PharmEasy – India’s leading online pharmacy platform – has recently experienced a significant downturn in its evaluation. The company’s valuation plummeted by a staggering 92% and dropped from a peak of $4.8 billion to a current value of $458 million. This sharp decline raises questions about the future of online pharmacies in India. What Are The Reasons […]
Gaurav Verma Elevated To Chief Business Officer At PharmEasy
Gaurav Verma has recently been elevated to the position of Chief Business Officer at PharmEasy. This promotion comes after a successful tenure as the Chief Marketing Officer, where he played a significant role in enhancing the brand’s visibility and driving growth strategies. The career journey of Gaurav Verma Gaurav’s journey with PharmEasy began in December […]
How Marketing Strategies Made Pharmeasy Stand Out in the Medicine Industry.
PharmEasy is an Indian online medicine delivery platform and a health-tech start-up. By providing easy delivery of medicines at the doorstep, the company made great progress in making healthcare products accessible in India. This online pharmacy platform has gained immense popularity and attention since the COVID-19 pandemic. One of the reasons behind the popularity of […]
PharmEasy Plans To Raise Rs 2,000-3,000 Crore via Its Rights Issue
API Holdings Ltd, a parent company of PharmEasy, is planning to raise a fund of Rs 2,000-3,000 crore via its rights issue. In an all-investors meeting, it was decided to raise this amount for the loan repayment to Goldman Sachs. The right issues will be done with existing and new investors, in which Manipal Group […]
Debt-Laden PharmEasy To Raise ₹2,400 Cr Through Right Issue At A 90% Discount
PharmEasy, India’s leading digital healthcare platform, made headlines for its daring decision. This article delves into PharmEasy’s latest move, shedding light on the company’s debt and the strategic decision to opt for a rights issue. Join us as we take a sneak peek into the analysis that lies ahead, unravelling this bold move’s implications and […]
How Did PharmEasy Make A Comeback With Positive Cash Flow?
PharmEasy, the big name in the online healthcare aggregator business, has been inheadlines. Recently, the company recorded a positive cash flow with its EBITDA of around Rs 16 crore. In addition, PharmEasy also reported that its operating revenue in April was Rs 600 crore, the highest since its inception. In the last few years, the […]
Reasons To Hold PharmEasy Unlisted Shares For The Long Term Ahead Its IPO
PharmEasy, a startup operating under the parent company API Holdings, is set to file its IPO and raise an amount of Rs 6,250 crores through a fresh issue of shares. The company filed a Draft Red Herring Prospectus (DRHP) in November 2021. India’s leading digital healthcare brand is set to enter the primary market. Will […]
Understanding PharmEasy Current Performance In Pre-IPO Market
API Holding Ltd, a parent company of PharmEasy, reported a fluctuating performance in the Pre-IPO market. Despite getting approval from the market regulator to launch an IPO, the company’s current performance is not up to expectations. Not only does it create a problem for PharmEasy, but it also gives rise to insecurity for its retail […]
